In order to help patients make informed treatment decisions, health care professionals need to understand the clinical data regarding the indications and efficacy of novel therapies. In addition, toxicity management, particularly with oral agents, can pose a unique challenge to pharmacists, nurses, and physicians as well as patients and caregivers.  Frequent patient-clinician communication and the education and involvement of a multi-disciplinary clinical team to ensure adequate safety monitoring and effective management of adverse events is imperative. Pharmacists play a critical role in patient education, monitoring and management of treatment-related toxicities and would benefit from a comprehensive review of novel treatments for metastatic bladder cancer.

LEARNING OBJECTIVES

Following this activity, participants should be able to:

• Describe the role of novel therapies in the treatment of metastatic bladder cancer
• Apply best practices for the management of common drug-related toxicities in patients with metastatic bladder cancer
• Prepare patient counseling points related to the use of novel treatment strategies in metastatic bladder cancer

Event starts: 11/05/2021 - 2:30pm

Event ends: 11/05/2021 - 3:30pm

Cost: FREE

More info: https://education.nccn.org/node/89345